Bio-Rad Laboratories (BIO)
NYSE:BIO

Bio-Rad Laboratories (BIO) Stock Price & Analysis

601 Followers

BIO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$344.63 - $670.62
Previous Close$476.94
Volume82.08K
Average Volume (3M)175.13K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$1.85B
Total Debt (Recent Filing)$1.38B
Price to Earnings (P/E)-2.4
Beta1.08
Next EarningsFeb 16, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-201.81
Shares Outstanding29,824,130
R-Squared0.27
Standard Deviation0.09
10 Day Avg. Volume135,654
30 Day Avg. Volume175,131
Price to Book (P/B)1.80
Price to Sales (P/S)5.66
Price to Cash Flow (P/CF)53.40
P/FCF Ratio-222.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside19.72% Upside
Rating ConsensusModerate Buy
Alpha0.00736
Number of Analyst Covering1


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

BIO FAQ

What was Bio-Rad Laboratories’s price range in the past 12 months?
Bio-Rad Laboratories lowest stock price was $344.63 and its highest was $670.62 in the past 12 months.
    What is Bio-Rad Laboratories’s market cap?
    Currently, no data Available
    When is Bio-Rad Laboratories’s upcoming earnings report date?
    Bio-Rad Laboratories’s upcoming earnings report date is Feb 16, 2023 which is in 8 days.
      How were Bio-Rad Laboratories’s earnings last quarter?
      Bio-Rad Laboratories released its earnings results on Oct 27, 2022. The company reported $2.6 earnings per share for the quarter, missing the consensus estimate of $2.782 by -$0.182.
        Is Bio-Rad Laboratories overvalued?
        According to Wall Street analysts Bio-Rad Laboratories’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Bio-Rad Laboratories pay dividends?
          Bio-Rad Laboratories does not currently pay dividends.
          What is Bio-Rad Laboratories’s EPS estimate?
          Bio-Rad Laboratories’s EPS estimate is $3.45.
            How many shares outstanding does Bio-Rad Laboratories have?
            Bio-Rad Laboratories has 24,749,308 shares outstanding.
              What happened to Bio-Rad Laboratories’s price movement after its last earnings report?
              Bio-Rad Laboratories reported an EPS of $2.6 in its last earnings report, missing expectations of $2.782. Following the earnings report the stock price went down -7.979%.
                Which hedge fund is a major shareholder of Bio-Rad Laboratories?
                Among the largest hedge funds holding Bio-Rad Laboratories’s share is Fisher Asset Management LLC. It holds Bio-Rad Laboratories’s shares valued at 62M.

                  ---

                  Bio-Rad Laboratories Stock Smart Score

                  The Bio-Rad Laboratories stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Bio-Rad Laboratories

                  Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  PerkinElmer
                  West Pharmaceutical Services
                  Avantor
                  Bio-Techne
                  Charles River Labs

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis